Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 333
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00743509 | A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced Sarcoma | ||
| NCT00644683 | A Pilot Observational Study to Assess Changes in Biochemical Parameters of Ovarian Reserve With Chemotherapy | ||
| NCT03570619 | Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations | ||
| NCT00239200 | Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma Esophagus | ||
| NCT01663272 | A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer | ||
| NCT00271011 | A Study of Mitomycin C, Irinotecan, and Cetuximab | ||
| NCT01794481 | Benefits of Exercise Training in Head and Neck Cancer Patients Undergoing Organ-Preserving Definitive Therapy | ||
| NCT04852471 | Improving Quality of Life Using Patient Reported Outcomes Measures Post-operative Via Text Messaging | ||
| NCT03352427 | Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterations | ||
| NCT00904345 | Study of Radiation (RT) Concurrent With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (SCC) | ||
| NCT00142571 | Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma | ||
| NCT01073436 | Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With Interferon-Alpha | ||
| NCT02037230 | Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas | ||
| NCT05945121 | Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation | ||
| NCT03121287 | Early Imaging Biomarkers in NSCLC | ||
| NCT04510311 | Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors | ||
| NCT02989714 | Phase Ib/II Trial of Interleukin-2 and PD-1 Checkpoint Inhibitor, Nivolumab In Metastatic Clear Cell Renal Cell Cancer | ||
| NCT02097732 | Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery | ||
| NCT00399321 | A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer | ||
| NCT03617484 | Bortezomib in Combination With Ibrutinib in Ibrutinib Relapsed Mantle Cell Lymphoma | ||
| NCT04503668 | Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients | ||
| NCT06915168 | CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer | ||
| NCT01663259 | Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive Patients | ||
| NCT04477200 | Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma | ||
| NCT04094844 | Health Information Technology System ("Roadmap 2.0") in the Context of Hematopoietic Cell Transplantation | ||
| NCT03927105 | Nivolumab and the Antagonistic CSF-1R Monoclonal Antibody Cabiralizumab (BMS-986227) in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma | ||
| NCT02679586 | Imaging Biomarker for Early Detection of Treatment Efficacy During Breast Cancer Neoadjuvant Chemotherapy | ||
| NCT00581529 | Partial Breast Irradiation Using Accelerated Intensity Modulated Radiotherapy | ||
| NCT01661114 | A Trial of Gemcitabine, Infusional 5-Fluorouracil and Cisplatin for Advanced Pancreatic and Biliary Cancers | ||
| NCT06234748 | Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer | ||
| NCT00135187 | Study of Combination Therapy With VELCADE, Doxil, and Dexamethasone (VDd) in Multiple Myeloma | ||
| NCT03561272 | The Validation of a Novel Adherence Method for Oral Oncolytics | ||
| NCT00156312 | Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine | ||
| NCT01210027 | A Study of Radiation Toxicity in the Liver Using MRI-Based Perfusion | ||
| NCT02436408 | VISmodegib for ORbital and Periocular Basal Cell Carcinoma | ||
| NCT01639417 | Pilot Functional Imaging Study to Evaluate Mechanisms Underlying Chronic Pain in Breast Cancer Patients | ||
| NCT00148135 | Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site | ||
| NCT00603057 | Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer | ||
| NCT00143884 | Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood | ||
| NCT06094621 | Effect of Pre-operative Virtual Visits on Patients With Head and Neck Cancer Undergoing Surgery | ||
| NCT00148070 | Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer | ||
| NCT00116961 | Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma | ||
| NCT00136175 | Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder | ||
| NCT00242190 | Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer | ||
| NCT01633541 | Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer | ||
| NCT00141739 | Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT) | ||
| NCT02277457 | Personalized Adaptive Radiation Therapy With Individualized Systemic Targeted Therapy (PARTIST) for Locally Advanced, Non-small Cell Lung Cancer With Genomic Driver Mutations | ||
| NCT01700036 | A Pilot Study of Alpha-1-Antitrypsin (AAT) in Steroid Refractory Acute Graft vs Host Disease | ||
| NCT06784336 | Phase II Study of Resistant Potato Starch Plus Deferasirox to Improve Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation | ||
| NCT00135200 | Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple Myeloma |
